FIELD: biotechnology.
SUBSTANCE: invention relates to the production of cell lines used for cell technologies in medicine. The resulting new cell line of mouse spindle cell sarcoma 9927 AlS SIO has stable cultural and morphological characteristics, is stored in the Specialized Collection of Vertebrate Cell Cultures of the Russian Collection of Cell Cultures under the registration number “РККК (П) 807Д”. The cell line is characterized by the expression of class I major histocompatibility complex antigens haplotype A*01;*02; B*07,*35; С*06*07, expression of tumor-associated antigens CD99, TFE3, MyoD1, Fli-1, vimentin, cancer-testicular antigens MAGEA1, SLLP1 and PRAME.
EFFECT: invention can be used to create biomedical cell products, cell models, to test the activity of various pharmaceuticals, to create diagnostic kits and test systems in order to develop new therapeutic approaches and drugs.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
HUMAN SYNOVIAL SARCOMA CELL LINE 716 SS MNV | 2020 |
|
RU2740800C1 |
CELL PRODUCT FOR LOADING AND ACTIVATION OF HUMAN DENDRITE CELLS | 2019 |
|
RU2714208C1 |
MOUSE SPINDLE CELL SARCOMA CELL LINE 164 MSar FE | 2023 |
|
RU2796351C1 |
HUMAN EMBRYONIC RHABDOMYOSARCOMA CELL LINE 862 RMSAR KDD | 2020 |
|
RU2737248C1 |
HUMAN BLADDER CANCER CELL LINE 198 BLCAN RLA | 2019 |
|
RU2733230C1 |
HUMAN OVARIAN CANCER CELL LINE 533 OOS | 2017 |
|
RU2650759C1 |
HUMAN COLORECTAL CANCER CELL LINE 485 COLO CAN | 2017 |
|
RU2650757C1 |
APPLICATION OF HUMAN SKIN MELANOMA CELL LINE 388mel | 2018 |
|
RU2675541C1 |
APPLICATION OF CELL LINE OF RC291C CLEAR CELL ADENOCARCINOMA | 2018 |
|
RU2673729C1 |
OSTEOGENIC HUMAN SARCOMA CELL LINE 793 OSSAR RVV | 2019 |
|
RU2722867C1 |
Authors
Dates
2023-05-22—Published
2022-11-21—Filed